Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
James C. Katzaroff currently holds 80,422,535 shares of GlobeStar Therapeutics Corp (GSTC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, James C. Katzaroff has been a net buyer of GSTC stock. They have purchased $91.4K and sold $46.4K worth of shares.
James C. Katzaroff's most recent insider trade was on Aug 28, 2023, when they purchased 11,111,111 shares at $0.00 per share.
James C. Katzaroff serves as Executive at GlobeStar Therapeutics Corp (GSTC). They have executed 69 insider transactions totaling $137.8K over their tenure at the company.
James C. Katzaroff holds the position of Executive at GlobeStar Therapeutics Corp, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
James C. Katzaroff has shown a buying trading pattern, with $91.4K in total purchases and $46.4K in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by James C. Katzaroff was on Feb 2, 2017, when they sold $772.7K worth of RDGL shares. This transaction involved 1,545,400 shares at $0.50 per share.
James C. Katzaroff currently owns 80,422,535 shares of GlobeStar Therapeutics Corp (GSTC), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of James C. Katzaroff's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. James C. Katzaroff has 69 Form 4 filings on record as an insider at GlobeStar Therapeutics Corp.
Set alerts for James C. Katzaroff and 40,000+ other insiders.